G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors
- PMID: 10344528
- DOI: 10.1007/pl00005355
G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors
Abstract
The effect of guanine nucleotide-binding protein (G protein) modifiers on the binding of the adenosine A2A receptor agonist 2-[4-(2-p-carboxyethyl[3H])phenyl-amino]-5'-N-ethylcarboxamidoadenosine ([3H]CGS 21680) and of the adenosine A1 receptor agonist [3H]R-phenylisopropyladenosine ([3H]R-PIA) to rat cortical and striatal membranes was studied. Guanosine 5'-(beta,gamma-imido)triphosphate (1-300 microM), which uncouples all G proteins, more effectively inhibited [3H]CGS 21680 (30 nM) binding in the cortex than [3H]R-PIA (2 nM) binding to cortical or striatal membranes or [3H]CGS 21680 (30 nM) binding in the striatum. N-Ethylmaleimide (1-300 microM) or pertussis toxin (1-100 microg/ml), which uncouple G(i)/G(o) protein-coupled receptors, more effectively inhibited [3H]R-PIA binding to cortical or striatal membranes and [3H]CGS 21680 binding in the cortex than [3H]CGS 21680 binding in the striatum. Cholera toxin (2.5-250 microg/ml), which uncouples G(S) protein-coupled receptors, more effectively inhibited [3H]CGS 21680 binding in the striatum than [3H]CGS 21680 binding in the cortex and less effectively inhibited [3H]R-PIA binding to cortical or striatal membranes. Treatment of solubilised cortical membranes with pertussis toxin (50 microg/ml) decreased [3H]CGS 21680 (30-100 nM) binding which almost fully recovered after reconstitution with G(i)/G(o) proteins. The K(i) for displacement of [2-3H]-(4{2-[7-amino-2-(2-furyl)(1,2,4)triazolo(2,3-a)(1,3,5)triazin+ ++-5-ylamino]ethyl}phenol) ([3H]ZM 241385, 1nM) by CGS 21680 was 110 nM (95%CI: 98-122 nM) in non-treated, 230 (167-292) nM in pertussis toxin (25 microg/ml)-treated and 222 (150-295) nM in cholera toxin (50 microg/ml)-treated cortical membranes; in contrast, the K(i) for displacement of [3H]-5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo(4,3-e)-1,2,4-triazol o(1,5-c)pyrimidine ([3H]SCH 58261, 1 nM) by CGS 21680 was 74 (57-91) nM in non-treated, 71 (44-100) nM in pertussis toxin-treated and 147 (100-193) nM in cholera toxin-treated cortical membranes. Finally, CGS 21680 displaced monophasically the binding of the A1 antagonist, [3H]8-cyclopentyl-1,3-dipropylxanthine (2 nM), and the A1 agonist, [3H]R-PIA (2 nM), in 2 or 10 mM Mg(2+)-medium, either at 25 degrees C or 37 degrees C, in cortical or striatal membranes. These results indicate that CGS 21680 does not bind to A1 receptors and that limbic CGS 21680 binding sites differ from striatal-like A2A receptors since they couple to G(i)/G(o) proteins, as well as to G(s) proteins.
Similar articles
-
Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.Br J Pharmacol. 1996 Apr;117(7):1381-6. doi: 10.1111/j.1476-5381.1996.tb15296.x. Br J Pharmacol. 1996. PMID: 8730729 Free PMC article.
-
Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.Naunyn Schmiedebergs Arch Pharmacol. 1996 Feb;353(3):261-71. doi: 10.1007/BF00168627. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8692280
-
Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.Br J Pharmacol. 1997 Jun;121(3):353-60. doi: 10.1038/sj.bjp.0701119. Br J Pharmacol. 1997. PMID: 9179373 Free PMC article.
-
Modulation of protein kinase C by adenosine: involvement of adenosine A1 receptor-pertussis toxin sensitive nucleotide binding protein system.Mol Cell Biochem. 1995 Aug-Sep;149-150:51-8. doi: 10.1007/BF01076563. Mol Cell Biochem. 1995. PMID: 8569749 Review.
-
Selective adenosine A2A receptor antagonists.Farmaco. 2001 Jan-Feb;56(1-2):87-90. doi: 10.1016/s0014-827x(01)01024-2. Farmaco. 2001. PMID: 11347973 Review.
Cited by
-
Release inhibitory receptors activation favours the A2A-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artery.Br J Pharmacol. 2002 May;136(2):230-6. doi: 10.1038/sj.bjp.0704686. Br J Pharmacol. 2002. PMID: 12010771 Free PMC article.
-
Selective block of adenosine A2A receptors prevents ischaemic-like effects induced by oxygen and glucose deprivation in rat medium spiny neurons.Br J Pharmacol. 2022 Oct;179(20):4844-4856. doi: 10.1111/bph.15922. Epub 2022 Jul 27. Br J Pharmacol. 2022. PMID: 35817954 Free PMC article.
-
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update.Pharmacol Rev. 2022 Apr;74(2):340-372. doi: 10.1124/pharmrev.121.000445. Pharmacol Rev. 2022. PMID: 35302044 Free PMC article. Review.
-
Adenosine A2A Receptors Shut Down Adenosine A1 Receptor-Mediated Presynaptic Inhibition to Promote Implementation of Hippocampal Long-Term Potentiation.Biomolecules. 2023 Apr 21;13(4):715. doi: 10.3390/biom13040715. Biomolecules. 2023. PMID: 37189461 Free PMC article.
-
Binding of adenosine receptor ligands to brain of adenosine receptor knock-out mice: evidence that CGS 21680 binds to A1 receptors in hippocampus.Naunyn Schmiedebergs Arch Pharmacol. 2004 Oct;370(4):270-8. doi: 10.1007/s00210-004-0970-1. Epub 2004 Sep 18. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15378230
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous